Allogene Therapeutics, Inc. (ALLO) Ownership

$2.21

north_east $0.04 (1.62%)
Day's range
$2.05
Day's range
$2.22

Allogene Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2024 30.03 M $84.08 M   -3.94% 14.35%
TPG GP A, LLC 11/14/2024 18.72 M $52.41 B   0.00% 8.95%
BLACKROCK FUNDING, INC. /DE 11/13/2024 17.77 M $49.76 M   100.00% 8.50%
VANGUARD GROUP INC 11/13/2024 8.33 M $23.32 M   1.61% 3.98%
STATE STREET CORP 11/14/2024 7.01 M $19.64 M   -8.54% 3.35%
CAPITAL WORLD INVESTORS 11/13/2024 6.90 M $19.31 M   0.00% 3.30%
LYNX1 CAPITAL MANAGEMENT LP 11/14/2024 6.20 M $17.37 B   178.35% 2.97%
PRIMECAP MANAGEMENT CO/CA/ 11/08/2024 5.67 M $15.87 M   -0.03% 2.71%
CITADEL ADVISORS LLC 11/14/2024 5.04 M $14.11 M   105.99% 2.41%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 4.84 M $13.55 M   -16.44% 2.31%
WOODLINE PARTNERS LP 11/14/2024 4.36 M $12.22 M   0.12% 2.09%
JPMORGAN CHASE & CO 12/26/2024 4.09 M $11.45 M   -0.91% 1.95%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 3.23 M $9.04 M   14.43% 1.54%
WILDCAT CAPITAL MANAGEMENT, LLC 11/08/2024 2.92 M $8.18 B   0.00% 1.40%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/15/2024 2.87 M $8.03 M   0.00% 1.37%
TWO SIGMA INVESTMENTS, LP 11/14/2024 2.80 M $7.83 M   -5.50% 1.34%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 2.73 M $7.65 M   7.05% 1.31%
PERCEPTIVE ADVISORS LLC 11/14/2024 2.73 M $7.63 M   0.00% 1.30%
TWO SIGMA ADVISERS, LP 11/14/2024 2.41 M $6.75 M   7.49% 1.15%
GOLDMAN SACHS GROUP INC 11/14/2024 2.16 M $6.06 M   41.34% 1.03%
VIDA VENTURES ADVISORS, LLC 10/08/2024 1.80 M $5.03 M   0.00% 0.86%
MORGAN STANLEY 11/14/2024 1.72 M $4.82 M   -20.19% 0.82%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/12/2024 1.63 M $4.58 M   461.58% 0.78%
VESTAL POINT CAPITAL, LP 11/14/2024 1.50 M $4.20 M   -31.82% 0.72%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 1.18 M $3.30 M   0.04% 0.56%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2024 1.05 M $2.94 M   73.54% 0.50%
TD ASSET MANAGEMENT INC 11/01/2024 677,140 $1.97 M   -15.29% 0.32%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 642,009 $1.80 M   -63.27% 0.31%
BANK OF AMERICA CORP /DE/ 11/14/2024 583,925 $1.63 M   34.95% 0.28%
ZACKS INVESTMENT MANAGEMENT 11/14/2024 516,601 $1.45 M   100.00% 0.25%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/13/2024 486,023 $1.36 M   1.17% 0.23%
SUPERSTRING CAPITAL MANAGEMENT LP 11/14/2024 478,115 $1.34 M   -30.70% 0.23%
NORDEA INVESTMENT MANAGEMENT AB 11/05/2024 451,006 $1.30 M   -28.94% 0.22%
JANE STREET GROUP, LLC 11/15/2024 437,721 $1.23 M   -27.67% 0.21%
CERITY PARTNERS LLC 11/12/2024 432,382 $1.21 M   0.05% 0.21%
COASTAL BRIDGE ADVISORS, LLC 11/14/2024 405,847 $1.14 M   -0.25% 0.19%
UBS GROUP AG 11/14/2024 347,340 $972,552   15.66% 0.17%
BARCLAYS PLC 11/19/2024 342,973 $959,000   101.48% 0.16%
BANK OF NEW YORK MELLON CORP 11/12/2024 317,619 $889,334   -12.35% 0.15%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 316,946 $887,449   -45.81% 0.15%
SWISS NATIONAL BANK 11/07/2024 264,900 $741,720   -7.70% 0.13%
MILLENNIUM MANAGEMENT LLC 11/14/2024 258,002 $722,406   43.63% 0.12%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 11/05/2024 254,845 $713,566   -43.97% 0.12%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 254,239 $711,869   6.35% 0.12%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2024 247,564 $694,552   -6.34% 0.12%
CAXTON ASSOCIATES LP 11/14/2024 242,102 $677,886   -48.06% 0.12%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 11/08/2024 236,696 $662,749   -3.76% 0.11%
ALLIANCEBERNSTEIN L.P. 11/14/2024 210,078 $588,218   0.00% 0.10%
AMERICAN CENTURY COMPANIES INC 11/12/2024 199,421 $558,379   21.94% 0.10%
SQUAREPOINT OPS LLC 11/14/2024 188,497 $527,792   48.86% 0.09%

Allogene Therapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of ALLO shares?

During the previous two years, 199 institutional investors and hedge funds held shares of Allogene Therapeutics, Inc.. The most heavily invested institutionals were:

FMR LLC: 30.03 M

TPG GP A, LLC: 18.72 M

BlackRock Funding, Inc. /DE: 17.77 M

VANGUARD GROUP INC: 8.33 M

STATE STREET CORP: 7.01 M

Capital World Investors: 6.9 M

What percentage of Allogene Therapeutics, Inc. stock is owned by institutional investors?

78.58% of Allogene Therapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at ALLO ?

Institutional investors have bought a total of 200.88 M shares in the last 24 months. This purchase volume represents approximately $443.94 M in transactions.